S4 Capital PLC (SFOR)
Industry Advertising Agencies
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
24.30p
Buy
24.50p
-2.00p (-7.55%)
Derriston Capital PLC has been created to consider opportunities within the medical technology industry. The Company's initial focus will be to acquire one or more companies operating in the medical products and devices sector.
Prices updated at 05 Jun 2025, 13:28 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Communication Services
Industry
Advertising Agencies
Chairman
Sir Martin Stuart Sorrell
CEO
-
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
7,166
Head office
12 St James’s Place
London
United Kingdom
SW1A 1NX
Key personnel
| Owner name | Salary | Bonus | All other compensation | Total compensation | Restricted stock award |
|---|---|---|---|---|---|
Mr. Rupert Roderick Faure Walker Non-Executive Director, Senior Independent Director | - | - | - | - | - |
Mr. Colin Richard Day Non-Executive Director | - | - | - | - | - |
Ms. Susan Rachel Prevezer Non-Executive Director | - | - | - | - | - |
Mr. Daniel Emile Pinto Non-Executive Director | - | - | - | - | - |
Ms. Elizabeth Buchanan Non-Executive Director | - | - | - | - | - |
Ms. Margaret Ma Connolly Non-Executive Director | - | - | - | - | - |
Ms. Peter Miles Young Non-Executive Director | - | - | - | - | - |
Ms. Radhika Radhakrishnan Executive Director, Chief Financial Officer | - | - | - | - | - |
Sir Martin Stuart Sorrell Executive Director, Chairman | - | - | - | - | - |
Top 5 shareholders
| Owner name | No. of shares | Share as % of port. | Last change | Portfolio % change | Date of portfolio | % Total assets |
|---|---|---|---|---|---|---|
| Third Avenue Management LLC | 112,363,772 | 15.18892 | 43752965 | - | 31 May 2025 | 18.34 |
| Third Avenue Value Equity | 37,881,317 | 2.42375 | 5266657 | 16.148128 | 31 May 2025 | 6.18 |
| Third Avenue Value Fund | 37,881,317 | 2.41086 | 5266657 | 16.148128 | 31 May 2025 | 6.18 |
| Third Avenue RE Int'l Value Composite | 32,614,660 | 2.14092 | 32614660 | - | 31 May 2025 | 5.32 |
| Patient Opportunity Trust | 30,000,000 | 0.84935 | - | - | 31 May 2025 | 4.90 |
Director dealings
| Date | Action | Name | Price | Value | No. of shares | Holding (%) | Additional info |
|---|---|---|---|---|---|---|---|
| 19 Jul 2024 | Exercise of Option | Ms. Mary Basterfield | - | - | 96,913 | 0.02 | As advised by the company |
| 19 Jul 2024 | Sale of Option | Ms. Mary Basterfield | 52.94 | 19,215 | 60,618 | 0.01 | As advised by the company |
Please note that past performance is not a reliable indicator of future returns.
